BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 17213460)

  • 21. Difference in the use of preventive services between fee-for-service plans and HMOs: is more better?
    Wang YR; Pauly MV
    Am J Manag Care; 2003 Apr; 9(4):293-301. PubMed ID: 12703673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse selection among multiple competing health maintenance organizations.
    Robinson JC; Gardner LB
    Med Care; 1995 Dec; 33(12):1161-75. PubMed ID: 7500657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods of providing prescription drug benefits in health plans.
    Curtiss FR
    Am J Hosp Pharm; 1986 Oct; 43(10):2428-35. PubMed ID: 3788994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A method for risk-adjusting employer contributions to competing health insurance plans.
    Robinson JC; Luft HS; Gardner LB; Morrison EM
    Inquiry; 1991; 28(2):107-16. PubMed ID: 1829709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The direct and indirect effects of cost-sharing on the use of preventive services.
    Solanki G; Schauffler HH; Miller LS
    Health Serv Res; 2000 Feb; 34(6):1331-50. PubMed ID: 10654834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is your organization ready to share financial risk with HMOs?
    Coyne JS; Simon SD
    Healthc Financ Manage; 1994 Aug; 48(8):30-4. PubMed ID: 10146042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Service-level selection by HMOs in Medicare.
    Cao Z; McGuire TG
    J Health Econ; 2003 Nov; 22(6):915-31. PubMed ID: 14604553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of prescription charges in a health maintenance organization.
    Karls TA; Peterson CR; Thielke TS
    Am J Hosp Pharm; 1989 Aug; 46(8):1562-6. PubMed ID: 2773960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designing benefits that are good for employees and for business.
    Kreig J; Hergenrader R
    Health Care Strateg Manage; 1997 Oct; 15(10):1, 21-3. PubMed ID: 10173409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.
    Gilman BH; Kautter J
    Health Serv Res; 2008 Apr; 43(2):478-95. PubMed ID: 18370964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMO strategies for managing workers' compensation claims.
    Gallagher PA
    Healthc Financ Manage; 1996 Mar; 50(3):40-4. PubMed ID: 10156585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An opportunity for HMOs to use marketing to increase enrollee satisfaction.
    Dwore RB; Murray BP; Parsons RP; Gustafson G
    Manag Care; 2001 Jan; 10(1):38-9, 43-5, 49-52 passim. PubMed ID: 11211329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare spending on HMOs and stand-alone drug plans: what is it worth to beneficiaries?
    Austin BJ
    Find Brief; 2008 Nov; 11(8):1-3. PubMed ID: 19035029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of prescription card service and mail-order drug programs on employers' prescription drug costs.
    Cave DG
    Benefits Q; 1994; 10(4):21-30. PubMed ID: 10138423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health plans keeping drug cost increases in check with programs that promote generics.
    Capitation Manag Rep; 2002 Jul; 9(7):101-3, 97. PubMed ID: 12164057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Policy implications of risk selection in Medicare HMOs: is the federal payment rate too high?
    Issue Brief Cent Stud Health Syst Change; 1996 Nov; (4):1-7. PubMed ID: 10539724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Companies leaning on workers in battle against pharmacy costs.
    Diamond F
    Manag Care; 2002 Nov; 11(11):44-5. PubMed ID: 12491858
    [No Abstract]   [Full Text] [Related]  

  • 38. HMO market penetration and costs of employer-sponsored health plans.
    Baker LC; Cantor JC; Long SH; Marquis MS
    Health Aff (Millwood); 2000; 19(5):121-8. PubMed ID: 10992659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring the economic value of HMOs.
    Beauregard TR
    Benefits Q; 1995; 11(2):16-8. PubMed ID: 10142757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A closer look at the managed care backlash.
    Cooper PF; Simon KI; Vistnes J
    Med Care; 2006 May; 44(5 Suppl):I4-11. PubMed ID: 16625063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.